Drug Type Degrader-antibody conjugates |
Synonyms Anti-CLL-1-GNE-987(DAC) |
Target |
Action degraders, modulators |
Mechanism BRD4 degraders(Bromodomain-containing protein 4 degraders), CLL-1 modulators(C-Type lectin domain family 12 member A modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |